The following Stanford Bio-X affiliated faculty members who have specifically indicated interest in mentoring and hosting a potential fellow. Please review this webpage, which includes each faculty's research profile, for details.
For faculty who are interested in potentially mentoring and hosting a fellow from this program, please email Dr. Heideh Fattaey and Stanford Bio-X to be included on the list.
The 11th request for proposals for the Visiting Scholar or Visiting Postdoc Fellowships at Stanford Bio-X funded by the Novo Nordisk Foundation (NNF) is currently live, and has a deadline of January 29, 2025 at 2pm CET (5am PST). Please visit this webpage for more information. To access the application, click here.
Dr. Xiaojing Gao hopes to provide answers to the question of how to design biological systems as “smart medicine” that sense patients’ states, process the information, and respond accordingly. To realize this vision, Dr.
Dr. Gary Darmstadt's research focuses on advancing child health and development in low resource settings and advancing gender equality and health globally. His research spans intervention development and introduction as well as processes of scaling up delivery of innovations in developing countries.
Dr. Matthew Wheeler is a physician scientist with interests in cardiomyopathies, rare and undiagnosed diseases, therapeutics and genomics. Dr. Wheeler has research training in both myocardial and skeletal muscle biology and genetics, genomics, and multi-scale networks and is a physician with interest and experience treating patients with hypertrophic cardiomyopathy and other inherited cardiomyopathies. I have clinical training in medicine, cardiology, cardiovascular genetics, and advanced heart failure.
Dr. Natalie Torok's lab investigates the molecular mechanisms of liver fibrosis, focusing on the role of oxidative pathways in non-alcoholic and alcoholic steatohepatitis.
Dr. Torok's lab has demonstrated the intricate link between hepatocyte cell death, generation of apoptotic bodies and their phagocytosis by stellate cells triggering fibrogenic activation. Key to this was the activation of the NADPH oxidase and production of reactive oxidative species inducing stellate cell transdifferentiation and collagen I transcription.
The consistent focus of Dr. Anna Gloyn's research has been using naturally occurring mutations in humans as tools to identity critical regulatory pathways and insights into normal physiology. Her early post-doctoral research led to the identification a new genetic aetiology for permanent and transient neonatal diabetes due to KCNJ11 mutations and resulted in one of the first examples of precision medicine, where the determination of the molecular genetic aetiology lead to improved treatment options for patients. Whilst she was in Oxford, Dr.
Dr. Wendy Gu's group studies the mechanical behavior of nanomaterials. They work at the intersection of solid mechanics, materials science and nano-chemistry. They research the unique properties of nanoscale metals, ceramics and nano-architected composites in order to design strong, tough and lightweight structural materials, materials for extreme environments, and mechanically-actuated sensors. The Gu group's experimental tools include nanoindentation, electron microscopy, and colloidal synthesis.
Dr. Claudia Petritsch's lab studies the involvement of stem and progenitor cells in gliomagenesis and novel therapeutic approaches for glioma using their own new in vivo models for pediatric and adult brain tumors for preclinical testing.
Dr. Robbie Majzner's laboratory focuses on engineering CAR T cells and other immunotherapeutics for children with cancer. Dr. Majzner has generated and optimized novel receptors to recognize antigens over-expressed on pediatric solid tumors such as GD2, B7-H3, and ALK. Current work focuses on imparting multi-specificity to CAR T cells and optimizing these receptors to enhance their efficacy when the amount of target (antigen density) is limiting.
